(Allergan plc)

	AGN latest price $220.5882 (-0.23%) ($218.8992 - $222.8177) on Wed. Sep. 3, 2014.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.12% (three month average)
RSI	92
Latest Price	$220.5882(-0.23%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.1% a day on average for past five trading days.
Weekly Trend	AGN advances 2.6% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(56%)    XBI(46%)    SPY(44%)    QQQ(42%)    VT(42%)
Factors Impacting AGN price	AGN will decline at least -0.56% in a week (0% probabilities).   VIXM(-33%)    TLT(-18%)    SHY(-8%)    IGOV(-6%)    GLD(-5%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.56% (StdDev 1.12%)
Hourly BBV	0 ()
Intraday Trend	-0.9%

5 Day Moving Average	$219.57(0.46%)
10 Day Moving Average	$219.04(0.71%)
20 Day Moving Average	$211.31(4.39%)
To recent high	-0.2%
To recent low	12.7%
Market Cap	$72.728b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed